Abstract:Tumor cells undergoing immunogenic cell death (ICD) release immunogenic damage-associated molecular patterns (DAMPs) to trigger a long-term protective antitumor response. ICD can be induced by certain pathogens, chemotherapeutics, and physical modalities. In this work, we demonstrate that a gaseous molecule, specifically nitric oxide (NO), can induce a potent ICD effect. NO exerts cytotoxic effects that are accompanied by the emission of DAMPs based on the endoplasmic reticulum stress and mitochondrial dysfunction pathways. Released DAMPs elicit immunological protection against a subsequent rechallenge of syngeneic tumor cells in immunocompetent mice. We prepare polynitrosated polyesters with high NO storage capacity through a facile polycondensation reaction followed by a postsynthetic modification. The polynitrosated polyesters-based NO nanogenerator (NanoNO) that enables efficient NO delivery and controlled NO release in tumors induces a sufficient ICD effect. In different immune-intact models of tumors, the NanoNO exhibits significant tumor growth suppression and increases the local dose of immunogenic signals and T cell infiltrations, ultimately prolonging survival. In addition, the NanoNO synergizes with the PD-1 blockade to prevent metastasis. We conclude not only that NO is a potent ICD inducer for cancer immunotherapy but also that it expands the range of ICD inducers into the field of gaseous molecules.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsnano.1c09048.Additional experimental data include agent list, chemical characterization of GSNO, NO detection, NO scavenger carboxy-PTIO and cell viability, NO-induced CRT exposure, NO distribution in tumors after it. injection, DAMP emission of DPTA NONOate-treated cells, NO-induced ER stress and mitochondria stress, NO's vaccination effects, characterization of NanoNO, biodistribution of NanoNO in tumors, antitumor therapy of NanoNO in multiple tumor models (PDF)This article has not yet been cited by other publications.

Arginine-assembly As NO Nano-Donor Prevents the Negative Feedback of Macrophage Repolarization by Mitochondrial Dysfunction for Cancer Immunotherapy

Nanostructured Organosilica Nitric Oxide Donors Intrinsically Regulate Macrophage Polarization with Antitumor Effect

Nanoparticle-enabled concurrent modulation of phagocytosis and repolarization of macrophages for enhanced cancer immunotherapy

[The Role of Nitric Oxide in the Cytotoxic Effect of Macrophages].

Dynamic Tagging to Drive Arginine Nano-Assembly to Metabolically Potentiate Immune Checkpoint Blockade Therapy.

Programmed Nanoreactors Boost Immune Response through ROS Cascade Amplification along with RNS Storm

A phosphatase-like nanomaterial promotes autophagy and reprograms macrophages for cancer immunotherapy

Immunomodulation of Tumor Microenvironment by Arginine-Loaded Iron Oxide Nanoparticles for Gaseous Immunotherapy

Acidity-Triggered Tumor-Targeted Nanosystem for Synergistic Therapy Via a Cascade of ROS Generation and NO Release

Engineered microparticles modulate arginine metabolism to repolarize tumor-associated macrophages for refractory colorectal cancer treatment

Reprogramming of breast tumor-associated macrophages with modulation of arginine metabolism

Reprogramming Tumor-Associated Macrophages by Nanoparticle-Based Reactive Oxygen Species Photogeneration

Repolarizing Tumor-Associated Macrophages and inducing immunogenic cell Death: A targeted liposomal strategy to boost cancer immunotherapy

Tumor-specific Nitric Oxide Generator to Amplify Peroxynitrite Based on Highly Penetrable Nanoparticles for Metastasis Inhibition and Enhanced Cancer Therapy

Chiral Ruthenium Nanozymes with Self‐Cascade Reaction Driven the NO Generation Induced Macrophage M1 Polarization Realizing the Lung Cancer "Cocktail Therapy"

NOX2 Enzyme Mimicking Nano‐Networks Regulate Tumor‐Associated Macrophages to Initiate Both Innate and Adaptive Immune Effects

Modulating Repolarization of Tumor-Associated Macrophages with Targeted Therapeutic Nanoparticles as a Potential Strategy for Cancer Therapy

Polarization of macrophages to an anti-cancer phenotype through in situ uncaging of a TLR 7/8 agonist using bioorthogonal nanozymes

Repolarizing tumor-associated macrophages by layered double hydroxide-based deacidification agent for tumor chemodynamic therapy and immunotherapy

Nitric Oxide Induces Immunogenic Cell Death and Potentiates Cancer Immunotherapy

Nanodrugs mediate TAMs-related arginine metabolism interference to boost photodynamic immunotherapy